Europe Opportunity Analysis for India Outbound Meetings, Incentives

India is one the youngest, yet the fastest growing economies of the world. India has a large thriving and vibrant market stuffed with millennial consumers. The newly rolled out open market policies to usher in FDI has impacted the GDP of the country. India is revamping its infrastructure to develop a comfortable passage for western investors. In the recent past, the bilateral ties between India and Europe have matured. Both the markets are coming closer with every passing day and developing an apt business friendly climate to promote and expedite the flow of business. India and EU are looking to repair the economic corridors between the two most steadily rising economies of the world. The Free Trade Agreement has bridged the strategic and economic gulf between both the markets and made India one of the most significant business partners of Europe. European exports to India have surged in the last few years. According to the RBI, the Indian exports to European markets amounts to INR 337 billion approximately. Apart from the core industries, the Indian tourism sector is extracting the benefits of the developing relationship between these two markets. The development of the tourism sector in India has enhanced the scene of the India Outbound Meetings, Incentives, Conferences, Exhibitions (MICE) Tourism Market to Europe.

The India Outbound Meetings, Incentives, Conferences, Exhibitions (MICE) Tourism Market to Europe & Forecast predicts a massive change in market behaviour in the coming few years. The significant change in the India Outbound MICE tourism market will reap the benefits of the economic bonhomie between India and Europe. It will not only expand the India outbound MICE tourism market to Europe, but this gesture shall surely create a suitable atmosphere for new jobs. In the recent past, the new market pacts in the tourism segment have encouraged the flow of inbound tourists in Europe from countries such as India. A flourishing tourism market of Europe and longer and stronger business tie-ups between Europe and India are favouring the growth of the India outbound MICE tourism market to Europe. The Government of India has doled out several investment friendly measures in the last few years. Initiatives such as Make in India and Digital India are complimenting the India MICE tourism market to Europe. In India segments such as Telecommunication and Energy are rising steadily and European investors are queuing up to invest in these maturing sectors. The Indian business fraternity and bureaucratic teams have travelled to different parts of Europe to promote India’s blooming economy. The new brigade of Indian businessmen is heavily investing in European markets and joining hands with their European counterparts to enhance their global presence. Companies such as Tata Steel, Motherson Sumi, Mahindra and Tata Motors are contributing greatly to European markets. Several Indian companies in the UK are growing and they have almost doubled their profits in a very short period of time.

Request For Report Sample: http://www.futuremarketinsights.com/reports/sample/rep-in-3008

India Outbound Meetings, Incentives, Conferences, Exhibitions (MICE) Tourism Market to Europe & Forecast: Game Changers

There are several factors that are promoting the growth of the India Outbound Meetings, Incentives, Conferences, Exhibitions (MICE) Tourism Market to Europe. The enhanced business ambience between the fastest growing regions of the world and revamped market policies are helping Indian business houses establish their footprint in the European market. The booming tourism market of India and the birth of a new breed of deep-pocketed travellers are cementing the ground for the growth of the India outbound MICE tourism market to Europe. Several investment friendly policies rolled out by European countries to woo investors are also speeding up the growth of the India outbound MICE tourism market to Europe.

India Outbound Meetings, Incentives, Conferences, Exhibitions (MICE) Tourism Market to Europe & Forecast: Restraints

Though the atmosphere and growth prospects between both the regions of the world have evolved with time, the recent Brexit referendum has stalled the growth of the India outbound MICE tourism market to Europe. Several India-based companies are shifting their focus from European markets for fetching better results. European markets are immensely competitive and dominated by powerful countries such as China. This is also dampening the flow of outbound investment of India into Europe. The tourism markets in other countries spread across the South-East Asia and Asia Pacific region are cheaper than the European markets and the costly markets of Europe are also barricading the India outbound MICE tourism market to Europe.

Request For TOC: http://www.futuremarketinsights.com/toc/rep-in-3008

India Outbound Meetings, Incentives, Conferences, Exhibitions (MICE) Tourism Market to Europe & Forecast: Bigwigs

Companies such as Thomas Cook, Itl World, Travel Corporation (India) Ltd. (Tci), and Tybros India Tours Private Limited are some of the key players dominating this segment.

This comprehensive report equips readers with lucid information and analysis on the sector. Future Market Insights’ experienced travel and tourism analysts bring to you accurate and unbiased information to help you make crucial decisions with confidence.

The report offers a 360° view – bringing to the fore key drivers, restraints, opportunities, and challenges prevailing in the sector. To offer readers actionable insights, detailed information on historical trends, current scenario, and future projections is provided in the report.

Browse Full Report: http://www.futuremarketinsights.com/reports/india-mice-tourism-sector-to-europe-outlook

ABOUT US:
Future Market Insights (FMI) is a leading market intelligence and consulting firm. We deliver syndicated research reports, custom research reports and consulting services, which are personalized in nature. FMI delivers a complete packaged solution, which combines current market intelligence, statistical anecdotes, technology inputs, valuable growth insights, an aerial view of the competitive framework, and future market trends.

Title:
Membrane Chemical Market Expected to Account for US$ 5,572.8 Mn by 2020
Radiopharmaceuticals Market Will hit at a CAGR of 5.9% by 2016 to 2026
Radiopharmaceuticals Market expected to grow at a CAGR of 5.9% during 2016 to 2026
Radiopharmaceuticals Market to Grow at a CAGR of 5.9% through 2026
Renewable Methanol Market by Primary Source: Biomass, Municipal Waste, Industrial Waste and Others
Hypercalcemia Treatment Market by End-use Application: Formaldehyde, MTBE, Gasoline, Dimethyl Ether and Solvents
Radiopharmaceuticals Market Poised to Rake US$ 8,500 million by 2026
Valuation of Radiopharmaceuticals Market to reach US$ 8,500 million by 2026
Radiopharmaceuticals Market Revenue is expected to US$ 8,500 million by 2026
Summary:
Future Market Insights has announced the addition of the “Radiopharmaceuticals Market: Global Industry Analysis and Opportunity Assessment, 2016–2026" report to their offering.
Radiopharmaceuticals Market, Radiopharmaceuticals, Radiopharmaceuticals Market sales, Radiopharmaceuticals Market size, Radiopharmaceuticals Market Forecast, U.K Radiopharmaceuticals Market, U.S Radiopharmaceuticals Market, India Radiopharmaceuticals Market.

North America is anticipated to be the most attractive regional market in the global radiopharmaceuticals market
North America accounted for more than 40% market share in the global radiopharmaceuticals market in 2016 and is expected to witness an increase of more than 100 BPS in its market share over the forecast period. In terms of Y-o-Y growth, North America dominated the global radiopharmaceuticals market and was valued at more than US$ 2,000 Mn in 2015. The market is expected to expand at 6.2% CAGR over the projected period to reach more than US$ 4,000 Mn by the end of 2026. The North America radiopharmaceuticals market is estimated to represent absolute $ opportunity of more than US$ 100 Mn in 2017 over 2016. The growth is stagnant and slow due to major reactors having been shut down in Canada and new reactors installed in place of old ones for better production of radioisotope. North America is expected to be the most lucrative market in the global radiopharmaceuticals market, recording an attractiveness index of 3.6.
Significant growth in the number of cancer and cardiovascular diseases patients in North America is expected to boost the global radiopharmaceuticals market
Widespread availability of SPECT and PET scanning machines will result in a growing number of radio diagnostic and radio therapeutics events in North America. For instance, the number of PET scanning machines installed per head of population in North America are more compared to that installed in Europe, thus leading to increased usage of radiotracers in the region. This growth in North America is expected to continue along with continuous technological improvements in PET scanning devices. The high level of awareness and accessibility to these machines is expected to account for high revenue generation in North America. This factor is boosting the overall growth of the global radiopharmaceuticals market. The other factor impacting the global radiopharmaceuticals market is the rising prevalence of cancer in North America. This has significantly increased the number of nuclear medicine procedures performed in the region and this is the precise reason that the market for radiopharmaceuticals is steadily growing in North America. There has been a rising number of cardiovascular diseases among the people in North America due to aging population, unhealthy food habits and rising obesity. The increasing number of cardiovascular patients is expected to boost the sales of radiopharmaceuticals, which would eventually create growth in the global radiopharmaceuticals market.
Request For Report Sample: http://www.futuremarketinsights.com/reports/sample/rep-gb-1992
Gallium-68 and Lutetium 177 sub-segments of the radioisotope segment are likely to dominate the North America radiopharmaceuticals market
Gallium-68 and Lutetium 177 are dominant sub-segments of the radioisotope segment in North America. Gallium-68 has gained immense popularity since the last one year in the field of nuclear medicine, especially in the diagnosis and evaluation of prostate cancer. This is in heavy reliance with incorporation of several technological leaps and entry of new radiotracer- 68Ga-PSMA-11, developed by the University of Heidelberg. Additionally, marketing authorisation of the first 68Ge/68Ga generator, manufactured by the German company Eckert & Ziegler, has also positively impacted the penetration of 68Ga-PSMA-11 tracer in the treatment of prostate cancer in North America. Despite a shorter half-life, Gallium-68 has an ideal profile as a PET imaging agent. Several manufacturers in North America are focussing on introducing cold kits for the 68Ga-labeling of tracers (ANMI, Belgium), thus opening the gateways for 68Ga in PET scanning. Iodine-131, a therapeutic radiotracer continues to be the ideal tracer for the treatment of not only thyroid cancer but also other therapeutic indications. However it is being slowly replaced by Lutetium-177 (Lu-177) in North America. Lu-177, low-energy β-particle emitter is identified to be one of the emerging radiotracers for the treatment of metastatic castrate-resistant prostate cancer (mCRPC) and neuroendocrine tumors.
Send An Enquiry: http://www.futuremarketinsights.com/askus/rep-gb-1992

Market share of companies operating in the global radiopharmaceuticals market
The global radiopharmaceuticals market is highly consolidated with a few companies that offer advanced technology systems and nuclear medicines for treating diseases. However, the global market is dominated by top five players accounting for over 89% share. Siemens Healthineers accounted for the largest share of around 41.2% of the global market in 2015. The company dominated the market owing to its diversified product portfolio, extensive geographical presence, and acquisition strategies. GE Healthcare accounted for the second largest share of around 30.1% and Mallinckrodt plc. accounted for the third largest share of around 9% in the global radiopharmaceuticals market.
Browse Full Report Radiopharmaceuticals Market Segmentation by Radioisotope – Technetium-99, Fluorine-18, Iodine-131, Leutetium-177, Yttrium-90, Gallium-68, Gallium-67, Rubidium-82, Iodine-123, Iodine-125, Indium-111; By Source – Cyclotrons, Nuclear Reactors; By Application – Oncology, Cardiology, Gastroenterology, Neuroendocrinology, Neurology, Nephrology; By End User – Hospitals, Diagnostic Imaging Centres, Ambulatory Surgical Centres, Cancer Research Institutes: http://www.futuremarketinsights.com/reports/radiopharmaceuticals-market
ABOUT US:
Future Market Insights (FMI) is a leading market intelligence and consulting firm. We deliver syndicated research reports, custom research reports and consulting services, which are personalized in nature. FMI delivers a complete packaged solution, which combines current market intelligence, statistical anecdotes, technology inputs, valuable growth insights, an aerial view of the competitive framework, and future market trends.
CONTACT:
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
F: +1-845-579-5705
Email: sales@futuremarketinsights.com
Website: www.futuremarketinsights.com

This release was published on openPR.